Outlook 2011 for US biotech: a boat load of optimism, but with caveats
This article was originally published in Scrip
Executive Summary
The optimism in the US biotech sector that began in early January has not let up, if the body language of presenters and attendees at the 13th annual Biotechnology Industry Organization (BIO) CEO and Investor Conference in New York City is anything to go by.